GHK-Cu Copper peptide and its effects on skin, repair and aging

Discovery and biology of GHK-Cu

Le GHK (glycyl-L-histidyl-L-lysine) was discovered in 1973 by Loren Pickart in human plasma during research on liver regeneration. It was quickly identified as a natural tripeptide with a high affinity for copper(II) ions — hence the notation GHK-Cu for the peptide-copper complex.

Plasma concentration of GHK-Cu is naturally high in young adults (~200 ng/ml at 20 years) and decreases significantly with age (~80 ng/ml at 60 years), a correlation that has directed research towards its roles in aging.

Mechanisms of action of GHK-Cu

Stimulation of collagen synthesis

GHK-Cu stimulates the synthesis of collagen (types I, III, and IV) and elastin in dermal fibroblasts. It also activates lysyl oxidase, the enzyme responsible for collagen cross-linking, thus improving the mechanical properties of the extracellular matrix.

Antioxidant activity and cell protection

Copper chelated by GHK acts as an enzymatic antioxidant via:

• Stimulation of superoxide dismutase (Cu/Zn-SOD)
• Reduction of hydroxyl radical production via the Fenton reaction
• Protecting DNA from oxidative damage

Modulation of gene expression (transcriptomics)

Transcriptomic studies (Pickart and Margolina, 2018) have shown that GHK-Cu modulates the expression of more than 4,000 human genes, notably :

• Inhibition of pro-inflammatory genes (TNF-α, IL-1β, NF-κB pathway)
• Activation of DNA repair genes (BRCA1, ATM, RAD51)
• Modulation of telomere length genes
• Upregulation of extracellular matrix synthesis genes
• Regulation of growth factors (VEGF, FGF, NGF)

Effects on tissue repair

GHK-Cu accelerates skin wound closure in multiple studies by stimulating stem cell migration, local angiogenesis, and matrix synthesis.

Applications in dermatological research

GHK-Cu is one of the few peptides to have been the subject of clinical studies in the dermatological field (medical cosmetics), although human data remain limited compared to in vitro/preclinical data:

• Controlled studies on the reduction of fine lines (improvement in skin density measured by ultrasound)
• Improvement in skin elasticity in double-blind studies (topical applications, 12 weeks)
• Reduction of hyperpigmented lesions in pilot studies
• Stimulation of follicular growth (in vitro data, murine models)

GHK-Cu and cellular aging

Beyond cutaneous applications, GHK-Cu is of interest to fundamental gerontology for its potential effects on the mechanisms of cellular aging:

• Telomeres: Data suggest a modulation of telomerase and protection against telomeric shortening (to be confirmed)
• Cellular senescence: reduction of senescence markers (β-galactosidase SA, p21) in aging fibroblasts in vitro
• Autophagy: stimulation of autophagy (cellular cleaning mechanism) in certain models

Specifications and available shapes

GHK-Cu in combination with other anti-aging peptides

In research on skin and systemic aging, GHK-Cu is often studied in combination with:

• Epithalon (Epithalamin): tetrapeptide studied for its effects on telomerase and cellular aging
• BPC-157: for combined tissue repair
• TB-500: for angiogenesis and cell migration

Sources: Pickart et al. 2015 — GHK-Cu skin regeneration · Pickart 2008 — GHK gene activation